ACS Publications. Most Trusted. Most Cited. Most Read
Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor
My Activity
    Article

    Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor
    Click to copy article linkArticle link copied!

    View Author Information
    Department of Chemistry and Biochemistry, University of North Carolina—Greensboro, Greensboro, North Carolina 27402, United States
    Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania 19140, United States
    *Center for Substance Abuse Research, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140. E-mail: [email protected]. Phone: 215-707-2638.
    *Department of Chemistry and Biochemistry, University of North Carolina—Greensboro, Greensboro, NC 27402. E-mail: [email protected]. Phone: 336-334-5333.
    Other Access OptionsSupporting Information (1)

    Biochemistry

    Cite this: Biochemistry 2017, 56, 3, 473–486
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.biochem.6b01013
    Published December 22, 2016
    Copyright © 2016 American Chemical Society

    Abstract

    Click to copy section linkSection link copied!
    Abstract Image

    GPR55 is a newly deorphanized class A G-protein-coupled receptor that has been implicated in inflammatory pain, neuropathic pain, metabolic disorder, bone development, and cancer. Few potent GPR55 ligands have been identified to date. This is largely due to an absence of information about salient features of GPR55, such as residues important for signaling and residues implicated in the GPR55 signaling cascade. The goal of this work was to identify residues that are key for the signaling of the GPR55 endogenous ligand, l-α-lysophosphatidylinositol (LPI), as well as the signaling of the GPR55 agonist, ML184 {CID 2440433, 3-[4-(2,3-dimethylphenyl)piperazine-1-carbonyl]-N,N-dimethyl-4-pyrrolidin-1-ylbenzenesulfonamide}. Serum response element (SRE) and serum response factor (SRF) luciferase assays were used as readouts for studying LPI and ML184 signaling at the GPR55 mutants. A GPR55 R* model based on the recent δ-opioid receptor (DOR) crystal structure was used to interpret the resultant mutation data. Two residues were found to be crucial for agonist signaling at GPR55, K2.60 and E3.29, suggesting that these residues form the primary interaction site for ML184 and LPI at GPR55. Y3.32F, H(170)F, and F6.55A/L mutation results suggested that these residues are part of the orthosteric binding site for ML184, while Y3.32F and H(170)F mutation results suggest that these two residues are part of the LPI binding pocket. Y3.32L, M3.36A, and F6.48A mutation results suggest the importance of a Y3.32/M3.36/F6.48 cluster in the GPR55 signaling cascade. C(10)A and C(260)A mutations suggest that these residues form a second disulfide bridge in the extracellular domain of GPR55, occluding ligand extracellular entry in the TMH1–TMH7 region of GPR55. Taken together, these results provide the first set of discrete information about GPR55 residues important for LPI and ML184 signaling and for GPR55 activation. This information should aid in the rational design of next-generation GPR55 ligands and the creation of the first high-affinity GPR55 radioligand, a tool that is sorely needed in the field.

    Copyright © 2016 American Chemical Society

    Read this article

    To access this article, please review the available access options below.

    Get instant access

    Purchase Access

    Read this article for 48 hours. Check out below using your ACS ID or as a guest.

    Recommended

    Access through Your Institution

    You may have access to this article through your institution.

    Your institution does not have access to this content. Add or change your institution or let them know you’d like them to include access.

    Supporting Information

    Click to copy section linkSection link copied!

    The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acs.biochem.6b01013.

    • Figures S-1–S-11, Tables S-1–Table S-5, results for the anandamide/GPR55 R* complex, results for the GSK494581A (R)/GPR55 R* complex, results for the GSK494581A (S)/GPR55 R* complex, and species differences noted for GSK benzoylpiperazines versus LPI (PDF)

    Terms & Conditions

    Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

    Cited By

    Click to copy section linkSection link copied!

    This article is cited by 20 publications.

    1. Laura Figuerola-Asencio, Paula Morales, Pingwei Zhao, Dow P. Hurst, Sommayah S. Sayed, Katsuya L. Colón, María Gómez-Cañas, Javier Fernández-Ruiz, Mitchell P. Croatt, Patricia H. Reggio, Mary E. Abood, Nadine Jagerovic. Thienopyrimidine Derivatives as GPR55 Receptor Antagonists: Insight into Structure–Activity Relationship. ACS Medicinal Chemistry Letters 2023, 14 (1) , 18-25. https://doi.org/10.1021/acsmedchemlett.2c00325
    2. Adam T. Guy, Feiqing Ding, Junpei Abe, Mariko Inoue, Yoshio Hirabayashi, Yukishige Ito, Hiroyuki Kamiguchi, Peter Greimel. Lysolipid Chain Length Switches Agonistic to Antagonistic G Protein-Coupled Receptor Modulation. ACS Chemical Neuroscience 2020, 11 (21) , 3635-3645. https://doi.org/10.1021/acschemneuro.0c00521
    3. Adam T. Guy, Koki Kano, Jyunpei Ohyama, Hiroyuki Kamiguchi, Yoshio Hirabayashi, Yukishige Ito, Ichiro Matsuo, Peter Greimel. Preference for Glucose over Inositol Headgroup during Lysolipid Activation of G Protein-Coupled Receptor 55. ACS Chemical Neuroscience 2019, 10 (1) , 716-727. https://doi.org/10.1021/acschemneuro.8b00505
    4. Eliza Korkus, Marcin Szustak, Rafal Madaj, Arkadiusz Chworos, Anna Drzazga, Maria Koziołkiewicz, Grzegorz Dąbrowski, Sylwester Czaplicki, Iwona Konopka, Edyta Gendaszewska-Darmach. Trans -palmitoleic acid, a dairy fat biomarker, stimulates insulin secretion and activates G protein-coupled receptors with a different mechanism from the cis isomer. Food & Function 2023, 14 (14) , 6496-6512. https://doi.org/10.1039/D2FO03412C
    5. Nephi Stella. THC and CBD: Similarities and differences between siblings. Neuron 2023, 111 (3) , 302-327. https://doi.org/10.1016/j.neuron.2022.12.022
    6. Naoki Harada, Mai Okuyama, Yoshiaki Teraoka, Yumi Arahori, Yoh Shinmori, Hiroko Horiuchi, Paula B. Luis, Akil I. Joseph, Tomoya Kitakaze, Shigenobu Matsumura, Tohru Hira, Norio Yamamoto, Takashi Iuni, Naoki Goshima, Claus Schneider, Hiroshi Inui, Ryoichi Yamaji. Identification of G protein-coupled receptor 55 (GPR55) as a target of curcumin. npj Science of Food 2022, 6 (1) https://doi.org/10.1038/s41538-021-00119-x
    7. Jinxuan Ren, Jiaqi Lin, Lina Yu, Min Yan. Lysophosphatidylcholine: Potential Target for the Treatment of Chronic Pain. International Journal of Molecular Sciences 2022, 23 (15) , 8274. https://doi.org/10.3390/ijms23158274
    8. Costanza Ceni, Michael J. Benko, Kawthar A. Mohamed, Giulio Poli, Miriana Di Stefano, Tiziano Tuccinardi, Maria Digiacomo, Massimo Valoti, Robert B. Laprairie, Marco Macchia, Simone Bertini. Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold. Pharmaceuticals 2022, 15 (7) , 768. https://doi.org/10.3390/ph15070768
    9. Paula Morales, Chanté Muller, Nadine Jagerovic, Patricia H. Reggio. Targeting CB2 and TRPV1: Computational Approaches for the Identification of Dual Modulators. Frontiers in Molecular Biosciences 2022, 9 https://doi.org/10.3389/fmolb.2022.841190
    10. Anthony English, Benjamin Land, Nephi Stella. Impact of adolescent THC exposure on later adulthood: Focus on mesocorticolimbic function and behaviors. 2022, 23-58. https://doi.org/10.1016/B978-0-12-823490-7.00010-1
    11. Alexandr Gish, Jean-François Wiart, Elodie Turpin, Delphine Allorge, Jean-Michel Gaulier. État de l’art et intérêt des dosages plasmatiques des substances endocannabinoïdes et endocannabinoïdes-like. Toxicologie Analytique et Clinique 2021, 33 (4) , 256-275. https://doi.org/10.1016/j.toxac.2021.07.004
    12. Maria Giovanna Mosca, Maria Mangini, Stefania Cioffi, Pasquale Barba, Stefania Mariggiò. Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning. Cell Communication and Signaling 2021, 19 (1) https://doi.org/10.1186/s12964-021-00727-w
    13. Junpei Abe, Adam T. Guy, Feiqing Ding, Peter Greimel, Yoshio Hirabayashi, Hiroyuki Kamiguchi, Yukishige Ito. Systematic synthesis of novel phosphoglycolipid analogues as potential agonists of GPR55. Organic & Biomolecular Chemistry 2020, 18 (41) , 8467-8473. https://doi.org/10.1039/D0OB01756F
    14. Israa H. Isawi, Paula Morales, Noori Sotudeh, Dow P. Hurst, Diane L. Lynch, Patricia H. Reggio. GPR6 Structural Insights: Homology Model Construction and Docking Studies. Molecules 2020, 25 (3) , 725. https://doi.org/10.3390/molecules25030725
    15. Jeremy D. Hill, Viviana Zuluaga-Ramirez, Sachin Gajghate, Malika Winfield, Uma Sriram, Slava Rom, Yuri Persidsky. Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation. Brain, Behavior, and Immunity 2019, 76 , 165-181. https://doi.org/10.1016/j.bbi.2018.11.017
    16. Christopher Lipina, Sarah K. Walsh, Sharon E. Mitchell, John R. Speakman, Cherry L. Wainwright, Harinder S. Hundal. GPR55 deficiency is associated with increased adiposity and impaired insulin signaling in peripheral metabolic tissues. The FASEB Journal 2019, 33 (1) , 1299-1312. https://doi.org/10.1096/fj.201800171R
    17. Jeremy D Hill, Viviana Zuluaga‐Ramirez, Sachin Gajghate, Malika Winfield, Yuri Persidsky. Activation of GPR55 increases neural stem cell proliferation and promotes early adult hippocampal neurogenesis. British Journal of Pharmacology 2018, 175 (16) , 3407-3421. https://doi.org/10.1111/bph.14387
    18. Feiqing Ding, Adam T. Guy, Peter Greimel, Yoshio Hirabayashi, Hiroyuki Kamiguchi, Yukishige Ito. Squaryl group modified phosphoglycolipid analogs as potential modulators of GPR55. Chemical Communications 2018, 54 (61) , 8470-8473. https://doi.org/10.1039/C8CC04467H
    19. Paula Morales, Dow P. Hurst, Patricia H. Reggio. Methods for the Development of In Silico GPCR Models. 2017, 405-448. https://doi.org/10.1016/bs.mie.2017.05.005
    20. Paula Morales, Patricia H. Reggio. An Update on Non-CB 1 , Non-CB 2 Cannabinoid Related G-Protein-Coupled Receptors. Cannabis and Cannabinoid Research 2017, 2 (1) , 265-273. https://doi.org/10.1089/can.2017.0036

    Biochemistry

    Cite this: Biochemistry 2017, 56, 3, 473–486
    Click to copy citationCitation copied!
    https://doi.org/10.1021/acs.biochem.6b01013
    Published December 22, 2016
    Copyright © 2016 American Chemical Society

    Article Views

    941

    Altmetric

    -

    Citations

    Learn about these metrics

    Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

    Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

    The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.